Glycaemic and Cardiometabolic Effects of Oral Semaglutide in Patients Aged ≥65 Years with Type 2 Diabetes

Endocrines 2026 Open access

Read full text
Authors: Antonio Maria Labate, Lorenzo Moretti, Provvidenza Villari
DOI: 10.3390/endocrines7010008
Cited by: 0
References: 31

Abstract

Background: Older patients with type 2 diabetes mellitus (T2DM) are often undertreated because of concerns regarding hypoglycaemia and clinical heterogeneity. Data on the effectiveness of oral semaglutide in this population remain limited. Methods: This observational study included 81 patients aged ≥65 years with T2DM treated with oral semaglutide for 12 months. Changes in glycaemic, anthropometric and cardiometabolic parameters were evaluated. The primary endpoint was achievement of HbA1c

Fields of Study & Subjects

Diabetes Treatment and Management Diabetes Management and Research Diabetes Cardiovascular Risks and Lipoproteins

Publication details

Journal / source
Endocrines
Volume
7
Issue
1
Pages
8–8
Publication date
3 March 2026
Language
EN